Informationen:
Fehler:
ID
12984
Beschreibung
Iressa Expanded Access Program (EAP); ODM derived from: https://clinicaltrials.gov/show/NCT00034879
Link
https://clinicaltrials.gov/show/NCT00034879
Stichworte
Versionen (1)
- 09.01.16 09.01.16 -
Hochgeladen am
9. Januar 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Carcinoma NCT00034879
Eligibility Carcinoma NCT00034879
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Carcinoma NCT00034879
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
non-small cell lung cancer
Item
previous documented histologically or cytologically confirmed non-small cell lung cancer;
boolean
C0007131 (UMLS CUI [1,1])
C0019638 (UMLS CUI [1,2])
C0007131 (UMLS CUI [2,1])
C0010819 (UMLS CUI [2,2])
C0019638 (UMLS CUI [1,2])
C0007131 (UMLS CUI [2,1])
C0010819 (UMLS CUI [2,2])
tumor stage, chemo-/radiotherapy, study participation, comorbidity
Item
locally advanced and/or metastatic non-operable non-small cell lung cancer (stage iii or iv)patients who have received at least one course of standard systemic chemotherapy or radiation therapy or are ineligible for chemotherapy or radiotherapy or are ineligible or not a candidate for enrollment on another zd1839 trial or who, in the investigator's opinion, are not medically suitable for chemotherapy.
boolean
C1300072 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
C2348568 (UMLS CUI [4])
C0009488 (UMLS CUI [5])
C0392920 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
C2348568 (UMLS CUI [4])
C0009488 (UMLS CUI [5])
age
Item
age 18 years or older;
boolean
C0001779 (UMLS CUI [1])
informed consent
Item
written informed consent to participate in the trial.
boolean
C0021430 (UMLS CUI [1])
therapy
Item
receiving concurrent radiotherapy, chemotherapy, or other systemic anti-cancer medication or any other investigational agent. * non-cytotoxic or hormonal therapies for the adjuvant treatment of cancer or for previously treated cancers may be allowed per astrazeneca permission;
boolean
C0087111 (UMLS CUI [1])
Study Subject Participation Status
Item
patients eligible for or previously enrolled on a zd1839 blinded clinical trial protocol. patients eligible for or previously enrolled on an open-label or unblinded zd1839 clinical trial may be considered for acceptance into the expanded access program with astrazeneca permission;
boolean
C2348568 (UMLS CUI [1])
malignancies
Item
having other active malignancies;
boolean
C0006826 (UMLS CUI [1])
surgery
Item
incomplete healing from previous oncologic or other major surgery;
boolean
C0038894 (UMLS CUI [1])
comorbidity
Item
evidence of any other significant clinical disorder or laboratory finding that makes it undesirable for the patient to participate in the trial;
boolean
C0009488 (UMLS CUI [1])
pregnancy, breast feeding
Item
pregnancy or breast feeding (women of child-bearing potential).
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])